当前位置:首页 - 行情中心 - 前沿生物-U(688221) - 财务分析

前沿生物-U

(688221)

  

流通市值:55.06亿  总市值:55.06亿
流通股本:3.75亿   总股本:3.75亿

前沿生物-U(688221)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润-0.97亿元,每股收益-0.26元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益104397.55万元,未分配利润-205383.45万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产166322.79万元,负债61925.24万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入58,639,825.8828,328,182.53129,472,935.9891,643,894.39
营业总成本159,170,063.1174,909,155.77405,686,029.6282,018,728.06
其他经营收益
营业利润-97,148,403.94-44,136,120.43-201,093,560.92-193,195,084.43
利润总额-97,352,610.68-44,121,517.41-201,382,610.39-193,457,754.17
净利润-97,352,610.68-44,121,517.41-201,382,610.39-193,457,754.17
每股收益
其他综合收益16,756.421,559.4611,919.84-9,917.82
综合收益总额-97,335,854.28-44,099,957.95-201,370,690.55-193,467,671.99
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,076,719,889.031,130,068,171.691,222,617,812.371,019,445,815.4
非流动资产:
非流动资产合计586,508,009.37593,674,627.65589,520,367.36986,182,222.26
资产总计1,663,227,898.41,723,742,799.341,812,138,179.732,005,628,037.66
流动负债:
流动负债合计373,554,542.67415,284,493.23395,204,569.94476,222,583.53
非流动负债:
非流动负债合计245,697,813.11211,246,867.16275,622,212.89380,191,038.67
负债合计619,252,355.78626,531,360.39670,826,782.83856,413,622.2
所有者权益(或股东权益):
归属于母公司股东权益合计1,043,975,542.621,097,211,438.951,141,311,396.91,149,214,415.46
股东权益合计1,043,975,542.621,097,211,438.951,141,311,396.91,149,214,415.46
负债和股东权益合计1,663,227,898.41,723,742,799.341,812,138,179.732,005,628,037.66
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计56,576,387.9627,612,104.41191,548,462.53131,499,749.84
经营活动现金流出小计154,804,229.6576,281,432.49364,064,774.58265,424,672.34
经营活动产生的现金流量净额-98,227,841.69-48,669,328.08-172,516,312.05-133,924,922.5
投资活动产生的现金流量:
投资活动现金流入小计1,556,639,373.5856,036,498.343,441,147,987.752,454,419,998.83
投资活动现金流出小计1,466,219,991.96793,652,130.913,631,929,445.542,822,987,050.27
投资活动产生的现金流量净额90,419,381.5462,384,367.43-190,781,457.79-368,567,051.44
筹资活动产生的现金流量:
筹资活动现金流入小计216,774,00039,000,000393,926,406.17324,609,468.99
筹资活动现金流出小计293,954,198.3883,419,439.56308,313,707.75274,795,091.37
筹资活动产生的现金流量净额-77,180,198.38-44,419,439.5685,612,698.4249,814,377.62
汇率变动对现金及现金等价物的影响-15,167.51-4,608.064,532.3313,432.76
现金及现金等价物净增加额-85,003,826.04-30,709,008.27-277,680,539.09-452,664,163.56
期末现金及现金等价物余额163,716,131.78218,010,949.55248,719,957.8273,736,333.35
补充资料:
现金及现金等价物的净增加额-85,003,826.04--277,680,539.09-
最新报告期:2025-09-08
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
国盛证券张金洋,胡偌碧,陈欣黎-0.53-0.40-0.562025-09-08
TOP↑